Clinical polygenic risk score testing for common cancers

Antegenes provides innovative genetic tests for medical professionals, utilizing polygenic risk score (PRS) technology.

The tests assess an individual’s genetic risk for common cancers, including breast (AnteBC), prostate (AntePC), colorectal (AnteCRC), and skin melanoma (AnteMEL).

Guidance for the clinical use of the breast cancer polygenic risk score testing
Learn more
Whitepaper - Breast cancer polygenic risk score test AnteBC
Learn more
Test description - Breast cancer polygenic risk score test AnteBC
Learn more
Polygenic risk score tests for common cancers
Learn more

Get in touch

Reach out to our dedicated team of healthcare professionals and discover solutions that prioritise your patients health and well-being

"*" indicates required fields